Location History:
- Murray, UT (US) (2011)
- Salt Lake City, UT (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: Kazuyuki Suzuki: Innovator in Therapeutic Compounds
Introduction
Kazuyuki Suzuki is a notable inventor based in Salt Lake City, UT. He has made significant contributions to the field of therapeutic compounds, holding two patents that focus on the treatment of abnormal cell growth.
Latest Patents
His latest patents include "Compounds and therapeutical use thereof," which discloses 4-arylamino-quinazolines and their analogs. These compounds are effective as activators of caspases and inducers of apoptosis. They are particularly useful in treating various clinical conditions characterized by uncontrolled growth and spread of abnormal cells. Another patent, "4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis," further emphasizes the therapeutic potential of these compounds in similar medical applications.
Career Highlights
Kazuyuki Suzuki is associated with Myrexis, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work has the potential to impact the treatment of serious health conditions.
Collaborations
He collaborates with notable colleagues, including Mark B Anderson and Sui Xiong Cai, contributing to a dynamic research environment.
Conclusion
Kazuyuki Suzuki's innovative work in therapeutic compounds showcases his commitment to addressing critical health challenges. His patents reflect a promising future in the treatment of abnormal cell growth.